B. Braun Medical acquires Dismed's hand sanitizer and intravenous fluid businesses in South Africa / Commitment to growth and local manufacturing for the African healthcare sector

Melsungen/Johannesburg (ots) - On 30 June 2016, B. Braun Medical,
the South African subsidiary of the German B. Braun Group, completed
its acquisition of Dismed Pharmaceutical (Pty) Ltd and Dismed
Criticare (Pty) Ltd, both out of business rescue.

With over 600 employees in South Africa, B. Braun specialises in
the sales and logistics of medical devices, surgical instruments,
consumables, pharmaceuticals and is one of the country's leading and
fastest growing operators of dialysis clinics. In 2011, B. Braun
Medical established its first local manufacturing site for medical
devices in Knysna, Western Cape.

"The Dismed acquisitions support our mission of being a system
supplier with a well-rounded portfolio of effective medical care
solutions in South Africa", said B. Braun Medical's managing
director, Jens Papperitz. "After resolving operational issues in both
acquired businesses, we will be able to offer our public and private
customers in Southern Africa the same level of excellence they have
come to expect from us based on our other product portfolio we
currently supply to them", added Papperitz.

With a triple digit million Rand spending for purchase price and
subsequent investments into production equipment, B. Braun Medical
ensures the continuing employment of all 120 staff at two
manufacturing facilities in Gauteng.

This investment into the healthcare and manufacturing sector is
also an indication of the confidence that the German business
community has in the South African health sector. This relationship
looks back on a healthy, longstanding trade relationship.

"Germany is the biggest foreign investor in South Africa within
the European Union and is responsible for creating 90,000 direct jobs
and another 90,000 indirect jobs", said Mr Matthias Boddenberg, Chief
Executive Officer of the Southern African-German Chamber of Commerce
and Industry. "That makes Germany a very important partner for South
Africa. The good infrastructure, the political stability and the
well-functioning legal system makes South Africa a good destination
for investments in the African continent."

Scott Farrell, Chief Financial Officer of B. Braun Medical, adds:
"We are grateful for the support from the various public authorities
we engaged with during this complex transaction. Following our
corporate claim "Sharing Expertise", we are fully committed to
further developing both the skills of our employees and a stronger
supplier network of BBBEE partners."

B. Braun is one of the world's leading manufacturers of medical
devices and pharmaceutical products and services. With over 56,000
employees in 64 countries, B. Braun develops high quality products,
systems and services for users around the world. In 2015, the Group
generated sales of approximately EUR6.1 billion.

Contact:
Jens Papperitz
Managing Director
B. Braun Medical (Pty) Limited
Email: jens.papperitz@bbraun.com
Tel: +27 10 222 3005